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Abstract
Introduction: Extracorporeal life support (ECLS) has recently shown encouraging results in the resuscitation of in-
hospital (IH) refractory cardiac arrest. We assessed the use of ECLS following out-of-hospital (OH) refractory cardiac
arrest.
Methods: We evaluated 51 consecutive patients who experienced witnessed OH refractory cardiac arrest and
received automated chest compression and ECLS upon arrival in the hospital. Patients with preexisting severe
hypothermia who experienced IH cardiac arrest were excluded. A femorofemoral ECLS was set up on admission to
the hospital by a mobile cardiothoracic surgical team.
Results: Fifty-one patients were included (mean age, 42 ± 15 years). The median delays from cardiac arrest to
cardiopulmonary resuscitation and ECLS were, respectively, 3 minutes (25th to 75th interquartile range, 1 to 7) and
120 minutes (25th to 75th interquartile range, 102-149). Initial rhythm was ventricular fibrillation in 32 patients
(63%), asystole in 15 patients (29%) patients and pulseless rhythm in 4 patients (8%). ECLS failed in 9 patients
(18%). Only two patients (4%) (95% confidence interval, 1% to 13%) were alive at day 28 with a favourable
neurological outcome. There was a significant correlation (r = 0.36, P = 0.01) between blood lactate and delay
between cardiac arrest and onset of ECLS, but not with arterial pH or blood potassium level. Deaths were the
consequence of multiorgan failure (n = 43; 47%), brain death (n = 10; 20%) and refractory hemorrhagic shock
(n = 7; 14%), and most patients (n = 46; 90%) died within 48 hours.
Conclusions: This poor outcome suggests that the use of ECLS should be more restricted following OH refractory
cardiac arrest.
Introduction
Out-of-hospital (OH) cardiac arrest remains an impor-
tant cause of unexpected death in developed countries.
It still has a low survival rate, despite access to
improved emergency medical care, the spread of auto-
matic defibrillation [1] and regularly updated interna-
tional guidelines [2]. Recent studies have indicated
unchanged or slightly better survival rates after OH
cardiac arrest over the past decades [3,4]. Initial
rhythm and cardiac origin are independent predictors
of successful cardiopulmonary resuscitation (CPR),
with better outcomes related to a shockable rhythm,
such as ventricular fibrillation, than asystole [5,6]. Sur-
vival rate rapidly decreases with time and refractory
cardiac arrest, defined as persistence of circulatory
arrest despite more than 30 minutes of appropriate
CPR, is usually considered a condition associated with
no survival [7], except in some particular conditions
such as hypothermia [8].
Extracorporeal life support (ECLS) has been suggested
as a therapeutic option in refractory cardiac arrest since
1976 [9]. However, the use of this technique has
remained limited to hypothermic cardiac arrest and those
cases occurring during the perioperative period of cardi-
othoracic surgery, mainly because the results of the initial
trials were disappointing [10,11]. The ease of use of more
recent miniaturized ECLS devices has permitted a wider
use of the technique. Encouraging results have been pub-
lished recently by several teams in France, Taiwan, Japan
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any medium, provided the original work is properly cited.and the United States [12-16]. In these studies, most car-
diac arrests occurred in the hospital, and survival with
good neurological outcome has been observed in up to
20% to 30% of cases [12-16]. Therefore, ECLS has been
assigned a low-grade recommendation in recent guide-
lines for in-hospital (IH) cardiac arrest [17].
However, the good results obtained in IH cardiac
arrest should not be extrapolated to OH cardiac arrest,
m a i n l yb e c a u s et h e r em a yb eal o n g e rd e l a yi nE C L S
initiation [18]. Our primary aim was to review the use
of ECLS for OH refractory cardiac arrest.
Materials and methods
This prospective observational study received approval
from our institutional review board (CPP Pitié-Salpê-
trière 2008/0701, Paris, France). Informed consent was
waived because of life-threatening emergencies and the
absence of any therapeutic alternative. Information was
delivered to the relatives of the patient (or to the patient
in cases of survival) after inclusion as appropriate in a
life-threatening context.
Patients
Over a 32-month period (from January 2008 to August
2010), all patients who were referred to our intensive
care unit (ICU) for OH refractory cardiac arrest were
eligible for enrollment into this study. They were
included prospectively and consecutively if the following
criteria were met: (1) witnessed OH cardiac arrest;
(2) refractory cardiac arrest, defined as the absence of a
return of spontaneous circulation (ROSC) after 30 min-
utes of CPR; (3) CPR was pursued until the patient’s
arrival at our ICU; (4) a mobile cardiothoracic surgery
team was available; and (5) a lack of known, severe
comorbidities that should have precluded admission into
an ICU. Patients who experienced IH cardiac arrest
were excluded, as well as patients who were severely
hypothermic (body temperature <32°C) before CPR.
Young children (<30 kg) were not included because our
institution exclusively takes care of adults and because
specific sizes of paediatric cannulae were not available.
Conversely, patients older than 70 years of age were
considered ineligible because of the poor expected neu-
rological recovery.
Protocol
The prehospital emergency medical service (EMS) team
performed CPR according to the American Heart Asso-
ciation guidelines [2]. In cases of refractory cardiac
arrest, CPR was pursued in the prehospital phase using
an automated device (AutoPulse; Zoll Inc., Chelmsford,
MA, USA) [19]. In the Paris area, all prehospital physi-
cian-staffed emergency units are equipped with an auto-
mated chest compression device because France has
developed a nationwide program of organ harvesting in
non-heart-beating donors. As soon as the EMS team
determined that initial CPR had failed, they immediately
alerted our ICU through the emergency unit regulating
centre to organize the patient admission and to ensure
the availability of the mobile cardiothoracic surgery
team. This unit works in our hospital and includes a
surgeon, a resident in surgery and a technician, together
with full equipment required to set up emergency ECLS
anywhere. This mobile cardiothoracic surgery team has
had extensive experience in our hospital and in our city
[12,20,21]. During transfer to the hospital, resuscitation
was continued without stopping at any moment.
At the admission to the ICU, the absence of ROSC and
the absence of a heartbeat were checked before engaging
in the procedure. Then mechanical ventilation and an
automated chest compression device were used until the
start of ECLS. ECLS was established surgically with per-
ipheral femorofemoral cannulation. The equipment used
included heparinized polyvinyl chloride tubing, a mem-
brane oxygenator (Quadrox Bioline; Jostra-Maquet,
Orleans, France) and venous and arterial femoral cannulae
(Biomedicus Carmed; Medtronic, Boulogne-Billancourt,
France) inserted surgically. An oxygen-air blender (Sechr-
ist; Sechrist Industries, Anaheim, CA, USA) was used to
supply the membrane oxygenator. Pump flow was initially
set at 3 to 4 L min
-1, and then arterial and central venous
catheters were inserted to continuously measure arterial
blood pressure and allow frequent blood sampling. To
avoid limb ischemia, an anterograde reperfusion catheter
for distal limb perfusion was inserted. Objectives to opti-
mize organ perfusion were partial pressure of oxygen
(PaO2) >100 mmHg, normocapnia and arterial blood pres-
sure >60 mmHg with administration of fluids, blood trans-
fusion to achieve a hematocrit level >35% or vasopressive
drugs (norepinephrine or epinephrine). Mild hypothermia
(target body temperature 33°C to 35°C) was maintained
during the first 24 hours using external cooling (pulsed-air
blanket), and neuromuscular blocking agents with seda-
tives were administered [22]. Minimum lung ventilation
was maintained to avoid pulmonary collapse during ECLS
with a tidal volume of 4 to 5 mL kg
-1, a respiratory rate of
6 breaths minute
-1 and positive end-expiratory pressure of
5 cmH2O. To avoid coagulation in the membrane oxyge-
nator, unfractionated heparin was intravenously adminis-
tered during ECLS with repeated control to maintain the
activated clotting time ratio >2.0, but this administration
was postponed in most patients because of major coagula-
tion abnormalities. An inhibitor of the proton pump was
systematically administered to prevent upper gastrointest-
inal bleeding. The possible cause of cardiac arrest was
immediately investigated with regular and repeated cardiac
troponin I (troponin Ic) assays, transthoracic or transoeso-
phageal echocardiography and an electrocardiogram as
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patients with strong indications of acute myocardial
infarction were transported to the catheter laboratory with
ECLS so that percutaneous coronary angiography and any
appropriate invasive treatments could be performed [23].
Sedation was stopped after a 24-hour period of mild
hypothermia, and then the patient’s neurological (clinical
examination and eventually electroencephalogram) and
infectious status were checked. Withdrawal from ECLS
required an echocardiographic assessment of myocardial
function (left ventricular ejection fraction >50%) and an
arterial blood PaO2-to-FiO2 (fraction of inspired oxygen)
ratio >150 mmHg. The pump flow was progressively
reduced to check for the absence of any deterioration in
hemodynamic status. The possibility of the use of a ventri-
cular assistance device or heart transplantation was exam-
ined if irreversible damage in myocardium function was
diagnosed with unsuccessful weaning from ECLS despite a
favourable neurological outcome. Discontinuation of
ECLS was based upon evidence of multiple organ failure
(MOF), massive bleeding or brain death. Any ECLS-
associated complications were carefully monitored.
Measurements
The following variables were recorded according to the
Utstein style [24]: age, sex, cardiovascular risk factors,
delays from collapse to basic CPR, advanced CPR, instal-
lation of automated chest compression device, arrival at
the ICU and installation of ECLS, initial cardiac rhythm,
use of vasopressor and defibrillation during initial CPR
and supposed cause of cardiac arrest. The patient’se n d
tidal CO2 (ETCO2) level during CPR and before ECLS
was also recorded [25]. During CPR, signs of life (that
is, respiratory gasps, movements) were noted.
The following biological measurements were per-
formed before ECLS: arterial blood gas analysis, blood
lactate (normal range, <1.8 mM L
-1), serum creatinine,
blood potassium, fibrinogen and prothrombin activity.
Troponin Ic level (normal range, <0.15 μgL
-1)( S t r a t u s
Autoanalyser; Dade-Behring, Paris La Défense, France)
and protein S100b level (normal range, <0.10 μgL
-1;
LIA-mat 300 analyzer, Byk-Sangtec France Laboratories,
Le Mée sur Seine, France) were also measured [26]. The
evolution of arterial pH and blood lactate levels was
recorded after 1 to 2 hours of ECLS, and the following
variables were calculated: change in arterial pH, blood
lactate clearance expressed as a percentage of initial
values and the number of patients with blood lactate
clearance less than or equal to -10% as previously
described [27].
The final outcome was determined at day 28, and the
Glasgow Outcome Scale score was determined at
6 months. The Glasgow Outcome Scale comprises the
following scores: 1, death; 2, persistent vegetative state;
3, severe disability (minimally conscious state, severe
motor deficit, aphasia and need for continuous help);
4, moderate disability; and 5, good recovery.
Since the start of our study (January 2009), French
guidelines for the indications for the use of ECLS in
refractory cardiac arrest have been published [28]. These
guidelines consider the following variables to determine
whether ECLS is indicated following OH cardiac arrest:
duration of no flow (≤5 min), duration of low flow
(≤100 min) and ETCO2 level (≥10 mmHg), at least in
nonhypothermic patients and in patients without life
signs during ongoing CPR (Additional file 1) [28]. Thus
we assessed whether the main criteria (no flow, low flow
and ETCO2 level) recommended in these guidelines
were followed during our study and if the whole algo-
rithm was respected.
Statistical analysis
Data are expressed as means ± SD or medians (25th to
75th interquartile range (IQR)) for non-Gaussian vari-
ables (Kolmogorov test). Categorical variables are given
as percentages with their 95% confidence intervals.
Comparison between two groups was performed using
Student’s t-test, the Mann-Whitney U test or Fisher’s
exact test as appropriate. Correlation between two vari-
ables was performed using least squares linear regres-
sion analysis. All P values were two-tailed, and a value
less than 0.05 was considered significant. Statistical ana-
lysis was performed using NCSS 6.0 software (Statistical
Solutions Ltd, Cork, Ireland).
Results
During the study period, we performed ECLS in 59
patients who had experienced refractory cardiac arrest.
Three patients who had experienced IH cardiac arrest, as
well as five patients with severe hypothermia (24.5°C ±
1.8°C) before cardiac arrest, were excluded. Thus, 51
patients were included in the study. The main character-
istics of our population are shown in Table 1. The sup-
posed causes of cardiac arrest were cardiac (n = 44, 86%),
trauma (n = 3, 6%), drug overdose (n = 2, 4%), respiratory
(n = 1, 2%) and electrocution (n =1 ,2 % ) .O n l yo n e
patient had signs of life during CPR before ECLS.
ECLS flow could not be established in nine (18%)
patients. These patients had a more prolonged no-flow
duration (medians, 3 minutes (IQR, 0.5 to 6.5) vs. 2.5
minutes (IQR, 1 to 6); P = 0.04) and lower mean ETCO2
levels (9 ± 3 minutes vs. 12 ± 2 minutes; P =0 . 0 4 6 )t h a n
the remaining patients. In one case, the failure was the
consequence of an impossible cannulation of the femoral
artery, probably related to an aortic dissection. The
remaining failures of ECLS were related to insufficient
pump flow despite massive fluid challenge and transfu-
sion. In the remaining 42 patients, the initial mean ECLS
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-1, providing a mean arterial
blood pressure of 67 ± 39 mmHg. During the ECLS pro-
cedure, 30 patients (59%) required blood transfusions
(median, 4 packed red blood cell units (range, 2 to 6)).
Mean body temperature was 34.1 ± 0.9°C.
Twenty (48%) of the 42 patients in whom ECLS was
initiated underwent coronary angiography because of
clinical or electrical signs suggesting myocardial infarc-
tion, but significant coronary abnormalities were noted
in only 10 (50%) of these patients. Angioplasty without
Table 1 Main characteristics of the patients (n = 51)
Variable Values Range
Mean age ± SD, yr 42 ± 15 13-70
Men, n (%) 46 (90%)
Women, n (%) 5 (10%)
Comorbidity, n (%)
Hypertension 6 (12%)
Diabetes mellitus 3 (6%)
Ischemic heart disease 11 (20%)
Other cardiac disease 10 (20)
Site of cardiac arrest, n (%)
Home 19 (37%)
Work 6 (12%)
Public 20 (39%)
Sport 6 (12)
Initial rhythm, n (%)
Ventricular fibrillation 32 (63%)
Asystole 15 (29%)
Pulseless rhythm 4 (8%)
Defibrillation
Patients receiving shock, n (%) 37 (72%)
Number of shocks, n (25th to 75th IQR) 4 (2 to 6) 1-20
Epinephrine
Patients receiving epinephrine, n (%) 51 (100%)
Dose (mg) 13 (10 to 20) 2-100
Mean end tidal CO2 ± SD, mmHg 22 ± 12 0-50
Delay, median (25th to 75th IQR)
Fall to basic CPR, min 3 (1 to 6) 0-22
Fall to advanced CPR, min 12 (5 to 23) 0-40
Fall to automated CPR, min 41 (30 to 55) 15-110
Fall to ICU admission, min 90 (65 to 115) 48-175
Fall to ECLS onset, min 120 (102 to 149) 75-195
Biological measurement
Arterial pH 6.93 ± 0.17 6.56-7.25
Mean blood lactate ± SD, mM L
-1 19.9 ± 6.7 7.7-40.8
Mean arterial bicarbonate ± SD, mM L
-1 16.5 ± 12.1 1.9-58.7
Mean PaO2 ± SD, mmHg 135 ± 129 6-489
Mean PaCO2 ± SD, mmHg 69 ± 25 19-128
Mean blood potassium ± SD
a,m ML
-1 5.1 ± 1.7 2.7-10.5
Mean serum creatinine ± SD, μML
-1 129 ± 30 51-275
Mean prothrombin time, % 39 ± 16 11-66
Median fibrinogene, g L
-1 (25th to 75th IQR) 1.3 (<0.6 to 1.6) <0.6-3.6
Mean hemoglobin ± SD, g L
-1 109 ± 25 59-169
Median troponin Ic, μgL
-1 (25th to 75th IQR) 3.98 (0.93 to 85.5) 0-669.0
Median protein S100
b, μgL
-1 (25th to 75th IQR) 4.2 (2.4 to 10.4) 0-36.0
CPR, cardiopulmonary resuscitation; ECLS, extracorporeal life support; ICU, intensive care unit; IQR, interquartile range; PaCO2, partial pressure of carbon dioxide;
PaO2, partial pressure of oxygen; troponin Ic, cardiac troponin I.
aBlood potassium could not be measured in four patients because of hemolysis;
bProtein S100 was measured in only 27 patients.
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stents following percutaneous transluminal angioplasty
were inserted in seven patients. Coronary spasm was
diagnosed in the two remaining patients.
Arterial blood gas samples at admission showed severe
lactic acidosis (Table 1). Initial blood lactate levels were
significantly correlated with the OH duration of cardiac
arrest until ECLS (P = 0.02) (Figure 1). In contrast, the
correlations between arterial pH (r = 0.05) or blood
potassium levels (r = 0.23) were not significant. After
1 hour of ECLS, blood lactate levels slightly but signifi-
cantly decreased, whereas arterial pH markedly increased
(Figure 2).
Seventeen (40%) of the 42 patients in whom ECLS was
initiated survived after 24 hours of ECLS, but only
5 (12%) survived after 48 hours. At day 28, only two
patients were alive, providing a global survival rate of
4% (95% confidence interval, 1% to 13%). The causes of
death were refractory MOF (n = 23; 45%), brain death
(n = 10; 20%) and severe haemorrhage (n = 7; 14%),
with the cause of death in the remaining patients being
failure of ECLS (n = 9; 18%).
In the first survivor (cardiac cause; ventricular fibrilla-
tion; no flow, 1 minute; low flow, 132 minutes; protein
S100 level, 1.5 μgL
-1), withdrawal from ECLS was possi-
ble only at day 36 because of severe, prolonged heart fail-
ure (left ventricular ejection volume estimated to be
30%), and an implantable automatic defibrillator was
inserted. This patient’sl e n g t ho fs t a yi nt h eI C Uw a s
58 days and IH was 187 days. Follow-up at 6 months
showed only minor cognitive dysfunction (Glasgow
Outcome Scale score 5) but a persistent altered left ven-
tricular ejection fraction (35%). In the second survivor
(cardiac cause; ventricular fibrillation; no flow, 0 minutes;
low flow, 170 minutes; protein S100 level, 4.5 μgL
-1),
withdrawal from ECLS was possible at day 5. This
patient’s length of stay in the ICU was 25 days and IH 77
days, with a Glasgow Outcome Scale score 4 at 6 months.
Conformity of the cases considering a no-flow period
≤5 minutes was noted in 36 patients (71%), a low-flow per-
iod ≤100 min in 14 patients (27%) and ETCO2 ≥10 mmHg
in 32 patients (63%). Conformity to the whole algorithm
of the French guidelines was seen in eight patients (16%).
Figure 3 shows the distribution of values of no flow, low
flow, arterial pH, blood lactate and potassium in patients
who died and in survivors. Although the two survivors ful-
filled the criterion of no flow less than 5 minutes, they did
not fulfill the criterion of low flow less than 100 minutes
(Figure 3). In an attempt to identify futile ECLS, we com-
pared patients who survived less than 24 hours with those
who survived more than 24 hours (post hoc comparison).
Only ETCO2 level (means, 18 ± 10 mmHg vs. 29 ± 12
mmHg; P = 0.006) and blood lactate clearance during
ECLS (medians, 11% (IQR, -24 to 26) vs. -22% (IQR, -26
to -1); P = 0.045) were significantly different between
patients who survived less than or more than 24 hours.
Discussion
Our primary objective in this study was to assess the use
of ECLS following OH refractory cardiac arrest. In a
selected population, we observed 4% survival with good
neurological outcomes. Although this survival rate is
close to that observed in the general population in
France who undergo nonrefractory OH cardiac arrest
[29], it represents a low survival rate compared with
rates in previous studies of ECLS in IH cardiac arrest.
Refractory cardiac arrest is defined by the lack of
ROSC within a period of at least 30 minutes of CPR in
the absence of preexisting hypothermia [1,28]. Because
this condition is associated with no survival, it is an
indication for stopping CPR and declaring the patient
dead. It indicates both the absence of the likelihood of
restoring cardiac activity and a poor chance of obtain-
ing a good neurological outcome. The introduction of
ECLS has created a new paradigm, since refractory car-
diac arrest might now be defined only as a function of
the possibility of obtaining a good neurological recov-
ery because ECLS supports cardiac function [27].
Recent publications have shown very encouraging
results, with 17% to 30% of survivors experiencing a
good neurological outcome [12-14,16,30]. Several stu-
dies and a meta-analysis have also reported favourable
outcome in children [29,31,32]. However, most of
these patients experienced IH cardiac arrest. The
marked difference in prognosis between IH and OH
Figure 1 Relationship between initial blood lactate level and
delay between fall and onset of extracorporeal life support
(ECLS) (n = 48).
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partly explained by a shorter treatment delay [18].
Kagawa et al. [15] compared IH and OH refractory
cardiac arrest treated with ECLS and reported a lower
survival rate in OH cardiac arrest (10% vs. 26%). Our
results cannot be extrapolated to patients with recur-
rent cardiac arrest [33] and to those with circulatory
failure after ROSC, in whom ECLS might be a thera-
peutic option. ECLS has also been used successfully in
patients with cardiogenic shock before cardiac arrest,
particularly in cases of severe drug intoxication [34].
Several factors may explain the low survival rate in OH
refractory arrest treated with ECLS. The most important
is probably the delay required to start ECLS (that is, low
flow), with the minimum being 75 minutes in our study,
whereas ECLS was started within 50 minutes in 50% of
patients in a previous study [14]. Some studies have
reported a relationship between the probability of survi-
val and low-flow duration [14], but some others did not
[32]. Part of this delay is unavoidable, but some time
could probably be saved by earlier alerting of the system
before reaching the 30-minute delay point until
Figure 2 Kinetic graph of (A) arterial pH and (B) arterial blood lactate during the first hour following extracorporeal life support
(ECLS) (n = 38). Boxplot represents the median, 25th to 75th interquartile range and extreme values.
Figure 3 Distribution of the values of no flow (top), low flow (middle) and end tidal CO2 (ETCO2) (bottom) initial arterial pH, blood
lactate and kalemia in the studied population (n = 51). The gray zones and vertical bars indicate the threshold considered in the French
guidelines for no flow (≤5 min), low flow (≤100 min) and ETCO2 (≥10 mmHg).
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duration may also be crucial, and the best candidates
remain those patients who benefit from immediate CPR
(that is, 0 no flow). The role of the delay until initiation
of advanced CPR may be far less important and was not
considered in the French guidelines [28], and the essen-
tial role of immediate CPR even without ventilation has
been largely confirmed [35]. However, other important
factors should be considered, particularly the quality of
CPR during ground transportation. The limited number
of people available to perform CPR during the prehospi-
tal phase and the difficulties associated with transporta-
tion are strong arguments for using an automated chest
compression device. However, the quality of CPR pro-
vided may not be optimal, since this device was demon-
strated to have failed to improve survival in a
r a n d o m i z e ds t u d y[ 1 9 ]a n dm a yb em o r eh e t e r o g e n e o u s
between patients than standard CPR.
Victims of refractory cardiac arrest are widely consid-
ered potential non-heart-beating organ donors [36].
From an ethical point of view, and beyond the dead
organ donor rule [37], it is essential that a clear separa-
tion exists between those patients who should be consid-
ered for organ donation and whose death is declared and
those patients who might benefit from a therapeutic
option such as ECLS. The French guidelines tried to help
the physician by explaining the contraindications for
ECLS in refractory cardiac arrest [28]. Our study suggests
that the criteria of no flow ≤5 minutes and ETCO2 level
≥10 mmHg remain appropriate, although the latter cri-
terion could be considered too liberal when taking into
account the lower ETCO2 level in patients who survive
less than 24 hours. In contrast, low flow ≤100 minutes
might be too restrictive, since a survivor was observed
after no flow 132 minutes (Figure 3) as previously
reported [12]. However, because of the low global survi-
val rate, extension of the criteria may not be suitable, and
most studies performed in IH cardiac arrest have consid-
ered only patients with low flow ≤100 minutes [13,14].
Thus, although the low-flow criteria may remain a matter
of debate, more criteria are warranted.
Prolonged CPR leads to severe lactic acidosis and
hyperkalemia, and we observed a more severe decrease
in pH than that observed in IH cardiac arrest [30].
Müllner et al. [38] demonstrated a significant correla-
tion between total duration of cardiac arrest and admis-
sion levels of arterial lactate concentration and observed
that a lactate level >16.3 mmol L
-1 was systematically
associated with impaired neurological recovery. How-
ever, this result may not apply to patients undergoing
ECLS, and although we observed a significant correla-
tion between the duration of low flow and blood lactates
(Figure 1), no precise threshold could be used to decide
whether to initiate ECLS (Figure 3) as previously noted
[12]. Arterial pH and blood potassium level are also
potential biological candidates. Nevertheless, the lack of
a significant relationship between low-flow duration and
these biological variables is not encouraging. The tropo-
nin Ic values are probably not useful, since they reflect
cardiac injury related to both CPR and the cause of car-
diac arrest. The value of protein S100 might be helpful,
although our survivors had elevated values. Although
most of the early deaths in our study were related to
MOF and massive haemorrhage, biological variables
exploring hemostasis abnormalities also do not seem
very interesting for that purpose. We consider that a
large multicentre study with an increased number of
survivors using multivariate analysis is mandatory to
improve the decision whether to perform ECLS in these
patients.
There is growing interest in measuring lactate clear-
ance [26,39]. We observed that ECLS induced a rapid
and marked increase in pH but a slight decrease in blood
lactate level during the first hours after ECLS (Figure 2).
Although there was no significant difference in arterial
pH change during ECLS between patients who survived
more than 24 hours and those who did not, blood lactate
clearance was significantly greater, suggesting that blood
lactate clearance may help to decide whether to initiate
earlier interruption of futile ECLS.
A potential limitation of a wider use of ECLS in
refractory cardiac arrest was the fear that it might lead
to the survival of patients with poor neurological recov-
ery and the associated use of costly resources and con-
siderable suffering for the patients and their relatives
[28]. Our study confirms that in nonsurvivors, death
occurs rapidly because of irreversible MOF or massive
haemorrhage. Moreover, most patients with isolated
brain injury evolved to brain death and not to a vegeta-
tive state. Compared to previous studies [12-15,30], we
observed a higher incidence of MOF and massive hae-
morrhage, probably because of the longer CPR duration,
and this finding is reflected by the major haemostasis
abnormalities observed before ECLS.
Some limitations in our study deserve consideration.
First, the sample size was relatively low. Nevertheless,
our study enables us to alert the medical community
about the risk of futile resuscitation in most cases of
OH refractory cardiac arrest. Second, the absence of a
control population of victims of cardiac arrest was ethi-
cally justified because the natural evolution of refractory
cardiac arrest remains death. Our results may not apply
to a paediatric population, since the cause of OH car-
diac arrest in children differs markedly from that in
adults. Because the respiratory causes are predominant
in children, refractory cardiac arrest may indicate that
the heart suffered from prolonged anoxia and thus that
severe brain damage has occurred.
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ECLS may be an appropriate therapeutic option in
patients following OH refractory cardiac arrest, since
survival with good neurological outcomes can be
observed. However, because the survival rate (4%)
remains markedly lower than that in patients with IH
refractory cardiac arrest,t h ei n d i c a t i o n sf o rE C L S
should be restricted to a highly selected population.
Further prospective, multicentre studies are needed to
define the population with OH refractory cardiac arrest
who would benefit from ECLS.
Key messages
￿ Extracorporeal life support (ECLS) has shown
encouraging results in the resuscitation of in-hospital
patients with refractory cardiac arrest.
￿ We assessed the use of ECLS following out-of-hos-
pital refractory cardiac arrest in 51 patients and
observed a low survival rate (4%).
￿ Further prospective multicentre studies are needed
to define the patient population with out-of-hospital
refractory cardiac arrest who would benefit from
ECLS.
Additional material
Additional file 1: Algorithm used to decide whether extracorporeal
life (ECL) support in treating patients in refractory cardiac arrest
(CA) is indicated. From Riou et al. [28]. CPR, cardiopulmonary
resuscitation; VT, ventricular tachycardia; VF, ventricular fibrillation; TP,
torsades de pointes; ETCO2, end tidal CO2 (measured 20 minutes after
the onset of medical CPR). *CPR duration >100 minutes could be
accepted in cases of poisoning with cardiac drugs. †Indications accepted
by ILCOR. Comorbidities are those which should contraindicate invasive
care (for example, admission to the intensive care unit, major surgery,
coronary angioplasty). The low-flow duration encompasses basic CPR
(witnesses and/or paramedics) and medical CPR.
Abbreviations
CPR: cardiopulmonary resuscitation; ECLS: extracorporeal life support; EMS:
emergency medical service; ETCO2: end tidal carbon dioxide; IH: in-hospital;
MOF: multiple organ failure; OH: out-of-hospital; ROSC: return of
spontaneous circulation.
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